Attached files

file filename
EX-99.1 - EXHIBIT 99.1 - POLYMEDIX, INCpressrelease.htm
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM 8−K

CURRENT REPORT
Pursuant to Section 13 OR 15 (d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): August 9, 2012


PolyMedix, Inc.
(Exact name of registrant as specified in its charter)

Delaware
 
000-51895
 
27-0125925
(State or other jurisdiction
of incorporation)
 
 
(Commission
File Number)
 
(I.R.S. Employer
Identification No.)
 

170 N. Radnor-Chester Road; Suite 300
Radnor, Pennsylvania
 
19087
(Address of principal executive offices)
 
(Zip Code)
 

Registrant’s telephone number, including area code: (484) 598-2400

Not Applicable
(Former name or former address, if changed since last report.)

Check the appropriate box below if the Form 8−K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
Soliciting material pursuant to Rule 14a−12 under the Exchange Act (17 CFR 240.14a−12)
Pre−commencement communications pursuant to Rule 14d−2(b) under the Exchange Act (17 CFR 240.14d−2(b))
Pre−commencement communications pursuant to Rule 13e−4(c) under the Exchange Act (17 CFR 240.13e−4(c))
 
 
 

 
 
Item 2.02 – Results of Operations and Financial Condition.

On August 9, 2012, PolyMedix, Inc. issued a press release announcing its financial results for the second quarter ended June 30, 2012. A copy of the press release is furnished herewith as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference.
 
Item 9.01 – Financial Statements and Exhibits.
 
 
(d) Exhibits
 
 
The following exhibit is being furnished herewith to this Current Report on Form 8-K.
 
 
Exhibit No.                      Description
 
 
99.1                      Press Release dated August 9, 2012.
 
 

 

SIGNATURE
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.


Date: August 9, 2012

 
PolyMedix, Inc.

By: /s/ Edward F. Smith
Name: Edward F. Smith
Title: Vice President, Finance and Chief Financial Officer

Exhibit Index
     
 
Exhibit
No.
 
 
 
Description of Exhibit
 
   
99.1
 
Press Release dated August 9, 2012.